MLVOX
Price
$21.57
Change
-$0.02 (-0.09%)
Updated
Sep 20 closing price
VFIAX
Price
$527.71
Change
-$1.02 (-0.19%)
Updated
Sep 20 closing price
Ad is loading...

MLVOX vs VFIAX

Header iconMLVOX vs VFIAX Comparison
Open Charts MLVOX vs VFIAXBanner chart's image
MFS Low Volatility Equity R2
Price$21.57
Change-$0.02 (-0.09%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Admiral
Price$527.71
Change-$1.02 (-0.19%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MLVOX vs VFIAX Comparison Chart
Loading...
VS
MLVOX vs. VFIAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLVOX is a StrongBuy and VFIAX is a Buy.

FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.24T vs. MLVOX (426M). VFIAX pays higher dividends than MLVOX: VFIAX (1.32) vs MLVOX (0.60). MLVOX was incepted earlier than VFIAX: MLVOX (11 years) vs VFIAX (24 years). MLVOX is a more actively managed with annual turnover of: 39.00 vs. VFIAX (2.00). MLVOX has a lower initial minimum investment than VFIAX: MLVOX (0) vs VFIAX (3000). VFIAX annual gain was more profitable for investors over the last year : 31.72 vs. MLVOX (18.53). VFIAX return over 5 years is better than : 90.47 vs. MLVOX (34.70).
MLVOXVFIAXMLVOX / VFIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years24 years-
Gain YTD16.54519.97183%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets426M1.24T0%
Annual Yield % from dividends0.601.3246%
Returns for 1 year18.5331.7258%
Returns for 3 years0.3630.991%
Returns for 5 years34.7090.4738%
Returns for 10 years116.11190.4861%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLBD54.491.17
+2.19%
Blue Bird Corp
MPLX44.200.07
+0.16%
Mplx LP
AIP7.45-0.08
-1.06%
Arteris
FFIN38.10-0.74
-1.91%
First Financial Bankshares
TPST1.35-0.06
-4.26%
Tempest Therapeutics